[Remote] Product Manager at Unlearn AI

San Francisco, California, United States

Apply Now

Not SpecifiedCompensation

N/AExperience Level

N/AJob Type

Not SpecifiedVisa

N/AIndustries

Requirements

At least 3 years experience as a product manager in a technology company working on technology-powered products
Bachelor’s degree or equivalent practical experience with demonstrated knowledge of the clinical development space
Demonstrated ability to ship high-impact products or features quickly
Demonstrated ability to figure out solutions to hard problems with many constraints, using sound judgment to assess risks, and to lay out your argument in a well-structured, data-informed, written narrative
Demonstrated ability to learn and partner with multiple functional areas of business – engineering, design, finance, sales, and marketing
Strong collaboration in team environments but able to act quickly as the decision-maker
Technical understanding must go from the highest abstractions down to the metal
Ability to get the data needed and create insightful stories
Owner’s mindset
Passion for the mission
Experience in biopharma industry or in clinical development (Nice to Have)

Responsibilities

Converse and collaborate with different types of teams including technology, marketing, and business development
Develop a deep understanding of the problems encountered by customers and users at biopharma companies while running clinical trials
Apply techniques and methods of modern product discovery and product delivery

Skills

Unlearn AI

Creates AI-driven digital twins for healthcare

About Unlearn AI

Unlearn.AI creates digital twins of patients using artificial intelligence, which are virtual replicas that simulate potential health outcomes. This technology allows healthcare providers to predict how a patient's health may change over time, leading to more informed treatment decisions. The primary clients include healthcare providers and pharmaceutical companies, who can use these digital twins in clinical trials to simulate control groups, potentially speeding up drug development and approval processes. Unlearn.AI differentiates itself by offering a unique simulation technology that reduces the need for actual human control groups, which can save time and resources. The company's goal is to enhance decision-making in patient care and drug development through precise health outcome predictions.

San Francisco, CaliforniaHeadquarters

2017Year Founded

$127.1MTotal Funding

SERIES_CCompany Stage

AI & Machine Learning, HealthcareIndustries

51-200Employees

Benefits

Health Insurance

Dental Insurance

Vision Insurance

401(k) Retirement Plan

401(k) Company Match

Unlimited Paid Time Off

Paid Holidays

Commuter Benefits

Paid Parental Leave

Company Equity

Risks

Over-reliance on AI data may lead to inaccuracies in trial outcomes.

Increased competition from companies like Consilx and Aicure could impact market share.

High clinical trial failure rates could affect perception of Unlearn AI's effectiveness.

Differentiation

Unlearn AI's TwinRCT uses digital twins to enhance clinical trial precision.

The company offers TrialPioneer, a free tool for innovative trial design exploration.

Unlearn AI's digital twin technology reduces the need for human control groups.

Upsides

AI in clinical trials market expected to reach $2.74 billion by 2030.

Partnership with ProJenX highlights AI's potential in specific therapeutic areas.

TwinRCT 3.0 enhances decision-making in Phase II trials for better outcomes.

Land your dream remote job 3x faster with AI

Try Jobo Free